Lipoprotein Lipase anticorps (AA 28-475)

N° du produit ABIN2724827

Cet anticorps Souris Monoclonal détecte spécifiquement Lipoprotein Lipase dans WB, IHC et IF. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Lipoprotein Lipase anticorps (AA 28-475) (ABIN2724827)

Antigène: Lipoprotein Lipase (LPL)

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Lipoprotein Lipase est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Clone: 6A10

Détail du produit anti-Lipoprotein Lipase anticorps

Épitope: AA 28-475

Attributs du produit: Homo sapiens lipoprotein lipase (LPL)

Purification: Purified from mouse ascites fluids by affinity chromatography

Immunogène: Human recombinant protein fragment corresponding to amino acids 28-475 of human LPL(NP_000228) produced in HEK293T cell.

Isotype: IgG1

Information d'application

Indications d'application: WB 1:500~2000, IHC 1:150, IF 1:100,

Commentaires:

The concentration of the product may vary between diferrent lots.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5-1.0 mg/mL

Buffer: PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur Lipoprotein Lipase

Antigène: Lipoprotein Lipase (LPL)

Autre désignation: LPL

Sujet: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.

Poids moléculaire: 50.3 kDa

ID gène: 4023

NCBI Accession: NM_000237

HGNC: 4023

Pathways: Lipid Metabolism